Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Understanding Functional Communication in Head and Neck Cancer Survivors Using a Mixed Methods Design.

Fletcher BS, Schumacher K, Cohen MZ, Kupzyk K, Lydiatt W.

Cancer Nurs. 2018 Feb 27. doi: 10.1097/NCC.0000000000000569. [Epub ahead of print]

PMID:
29489478
2.

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

Byrd TT, Fousek K, Pignata A, Szot C, Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K, Landi D, Rainusso N, Hicks J, Powell S, Baker ML, Wels WS, Koch J, Sorensen PH, Deneen B, Ellis MJ, Lewis MT, Hegde M, Fletcher BS, St Croix B, Ahmed N.

Cancer Res. 2018 Jan 15;78(2):489-500. doi: 10.1158/0008-5472.CAN-16-1911. Epub 2017 Nov 28.

PMID:
29183891
3.

Dystrophin is a tumor suppressor in human cancers with myogenic programs.

Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, Fox EA, Antonescu CR, Fletcher CD, Guo X, Raut CP, Demetri GD, van de Rijn M, Ordog T, Kunkel LM, Fletcher JA.

Nat Genet. 2014 Jun;46(6):601-6. doi: 10.1038/ng.2974. Epub 2014 May 4.

4.

The cancer family caregiving experience: an updated and expanded conceptual model.

Fletcher BS, Miaskowski C, Given B, Schumacher K.

Eur J Oncol Nurs. 2012 Sep;16(4):387-98. doi: 10.1016/j.ejon.2011.09.001. Epub 2011 Oct 14. Review.

5.

Tumor endothelial marker 8 expression in triple-negative breast cancer.

Gutwein LG, Al-Quran SZ, Fernando S, Fletcher BS, Copeland EM, Grobmyer SR.

Anticancer Res. 2011 Oct;31(10):3417-22.

PMID:
21965755
6.

Delivery of small interfering RNA (siRNA) using the sleeping beauty transposon.

Fletcher BS.

Cold Spring Harb Protoc. 2010 Nov 1;2010(11):pdb.prot5521. doi: 10.1101/pdb.prot5521.

PMID:
21041394
7.

What is the impact of medical education in the early years?

Fletcher BS.

J R Soc Med. 2009 Dec;102(12):507. doi: 10.1258/jrsm.2009.09k067. No abstract available.

8.

PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Saridey SK, Liu L, Doherty JE, Kaja A, Galvan DL, Fletcher BS, Wilson MH.

Mol Ther. 2009 Dec;17(12):2115-20. doi: 10.1038/mt.2009.234. Epub 2009 Oct 6.

9.

Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

Fernando S, Fletcher BS.

Cancer Res. 2009 Jun 15;69(12):5126-32. doi: 10.1158/0008-5472.CAN-09-0725.

10.

Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice.

Liu L, Liu H, Mah C, Fletcher BS.

Gene Ther. 2009 Jun;16(6):724-33. doi: 10.1038/gt.2009.13. Epub 2009 Mar 5.

PMID:
19262614
11.

Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer.

Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, Lee K, Aouizerat B, Swift P, Wara W, Miaskowski CA.

J Clin Oncol. 2008 Feb 1;26(4):599-605. doi: 10.1200/JCO.2007.12.2838.

PMID:
18235118
12.

Development and validation of an approach to produce large-scale quantities of CpG-methylated plasmid DNA.

Fletcher BS.

Microb Biotechnol. 2008 Jan;1(1):62-7. doi: 10.1111/j.1751-7915.2007.00007.x.

13.

Seasonal phenology of Bactrocera minax (Diptera: Tephritidae) in western Bhutan.

Dorji C, Clarke AR, Drew RA, Fletcher BS, Loday P, Mahat K, Raghu S, Romig MC.

Bull Entomol Res. 2006 Oct;96(5):531-8.

PMID:
17092364
14.

Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats.

Liu L, Liu H, Visner G, Fletcher BS.

FASEB J. 2006 Dec;20(14):2594-6. Epub 2006 Oct 25.

PMID:
17065228
15.

Sleeping Beauty-based gene therapy with indoleamine 2,3-dioxygenase inhibits lung allograft fibrosis.

Liu H, Liu L, Fletcher BS, Visner GA.

FASEB J. 2006 Nov;20(13):2384-6. Epub 2006 Oct 2.

PMID:
17015408
16.

Sleeping beauty transposon-mediated nonviral gene therapy.

Fernando S, Fletcher BS.

BioDrugs. 2006;20(4):219-29. Review.

PMID:
16831021
17.
18.

Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury.

Liu H, Liu L, Fletcher BS, Visner GA.

Am J Respir Crit Care Med. 2006 Mar 1;173(5):566-72. Epub 2005 Nov 17.

PMID:
16293800
19.

Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.

Johnson JS, Roux KJ, Fletcher BS, Fortun J, Notterpek L.

J Neurosci Res. 2005 Dec 15;82(6):743-52.

PMID:
16273544
20.

Hyperactive transposase mutants of the Sleeping Beauty transposon.

Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS.

Mol Ther. 2005 Dec;12(6):1148-56. Epub 2005 Sep 8.

21.

The WD-repeat protein GRWD1: potential roles in myeloid differentiation and ribosome biogenesis.

Gratenstein K, Heggestad AD, Fortun J, Notterpek L, Pestov DG, Fletcher BS.

Genomics. 2005 Jun;85(6):762-73.

PMID:
15885502
22.

Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.

Fortun J, Li J, Go J, Fenstermaker A, Fletcher BS, Notterpek L.

J Neurochem. 2005 Mar;92(6):1531-41. Erratum in: J Neurochem. 2005 May;93(3):766-8.

23.

Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22.

Roux KJ, Amici SA, Fletcher BS, Notterpek L.

Mol Biol Cell. 2005 Mar;16(3):1142-51. Epub 2005 Jan 5.

24.

Endothelial targeting of the Sleeping Beauty transposon within lung.

Liu L, Sanz S, Heggestad AD, Antharam V, Notterpek L, Fletcher BS.

Mol Ther. 2004 Jul;10(1):97-105.

25.

Transposon-based RNAi delivery system for generating knockdown cell lines.

Heggestad AD, Notterpek L, Fletcher BS.

Biochem Biophys Res Commun. 2004 Apr 9;316(3):643-50.

PMID:
15033448
26.

Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes.

Kumar A, Xiao YP, Laipis PJ, Fletcher BS, Frost SC.

Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E568-76. Epub 2003 Dec 9.

27.

Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression.

Fletcher BS, Dragstedt C, Notterpek L, Nolan GP.

Leukemia. 2002 Aug;16(8):1507-18.

28.

Glycogen phosphorylase is activated in response to glucose deprivation but is not responsible for enhanced glucose transport activity in 3T3-L1 adipocytes.

McInerney M, Serrano Rodriguez G, Pawlina W, Hurt CB, Fletcher BS, Laipis PJ, Frost SC.

Biochim Biophys Acta. 2002 Feb 15;1570(1):53-62.

PMID:
11960689
29.

Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia.

Notterpek L, Roux KJ, Amici SA, Yazdanpour A, Rahner C, Fletcher BS.

Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14404-9. Epub 2001 Nov 20.

30.
31.

Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

Kawaguchi H, Pilbeam CC, Gronowicz G, Abreu C, Fletcher BS, Herschman HR, Raisz LG, Hurley MM.

J Clin Invest. 1995 Aug;96(2):923-30.

32.
33.

Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene.

Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK.

Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5252-6.

34.

The tis genes, primary response genes induced by growth factors and tumor promoters in 3T3 cells.

Herschman HR, Kujubu DA, Fletcher BS, Ma Q, Varnum BC, Gilbert RS, Reddy ST.

Prog Nucleic Acid Res Mol Biol. 1994;47:113-48. Review. No abstract available.

PMID:
8016319
35.

Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells.

Kujubu DA, Reddy ST, Fletcher BS, Herschman HR.

J Biol Chem. 1993 Mar 15;268(8):5425-30.

36.

TIS10, a mitogen-inducible glucocorticoid-inhibited gene that encodes a second prostaglandin synthase/cyclooxygenase enzyme.

Herschman HR, Fletcher BS, Kujubu DA.

J Lipid Mediat. 1993 Mar-Apr;6(1-3):89-99. No abstract available.

PMID:
8358019
37.

Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse.

Wen PZ, Warden C, Fletcher BS, Kujubu DA, Herschman HR, Lusis AJ.

Genomics. 1993 Feb;15(2):458-60. No abstract available.

PMID:
8449520
38.
39.

Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters.

Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR.

J Biol Chem. 1991 Aug 5;266(22):14511-8.

40.

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR.

J Biol Chem. 1991 Jul 15;266(20):12866-72.

41.

Sex pheromone production in irradiated males of Dacus (Strumeta) tryoni.

Fletcher BS, Giannakakis A.

J Econ Entomol. 1973 Feb;66(1):62-7. No abstract available.

PMID:
4690298
42.

Storage and release of a sex pheromone by the Queensland fruit fly, Dacus tryoni (Diptera: Trypetidae).

Fletcher BS.

Nature. 1968 Aug 10;219(5154):631-2. No abstract available.

PMID:
5665720

Supplemental Content

Loading ...
Support Center